Clinical Trials Logo

Acne clinical trials

View clinical trials related to Acne.

Filter by:

NCT ID: NCT02965456 Completed - Acne Clinical Trials

Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Start date: November 4, 2015
Phase: Phase 3
Study type: Interventional

The objective of this study was to evaluate the efficacy, safety, and tolerability of a once daily topical application of IDP-121 Lotion compared with its vehicle (IDP-121 Vehicle Lotion) in participants with moderate to severe acne vulgaris (acne) (that is, acne having an Evaluator's Global Severity Score [EGSS] of 3 [moderate] or 4 [severe]).

NCT ID: NCT02944461 Completed - Acne Clinical Trials

Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris

Start date: October 2016
Phase: Phase 4
Study type: Interventional

To determine if Dapsone (Aczone) 7.5% gel is a safe and effective treatment for acne on the trunk

NCT ID: NCT02932306 Completed - Acne Clinical Trials

Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Start date: November 3, 2015
Phase: Phase 3
Study type: Interventional

The objective of this study was to evaluate the efficacy, safety, and tolerability of a once daily topical application of IDP-121 Lotion compared with its vehicle (IDP-121 Vehicle Lotion) in participants with moderate to severe acne vulgaris (acne) (that is, acne having an Evaluator's Global Severity Score [EGSS] of 3 [moderate] or 4 [severe]).

NCT ID: NCT02850003 Completed - Acne Clinical Trials

Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel

Start date: June 2016
Phase: Phase 1
Study type: Interventional

Study designed to assess the safety and plasma PK of tretinoin and its metabolites from topically applied IDP-120 gel.

NCT ID: NCT02849873 Completed - Acne Clinical Trials

Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac Cream

Start date: June 2016
Phase: Phase 1
Study type: Interventional

The Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison with Tazorac Cream.

NCT ID: NCT02849860 Completed - Acne Clinical Trials

Absorption and Systematic Pharmacokinetics of IDP-121 Lotion in Subjects With Acne Vulgaris

Start date: February 2014
Phase: Phase 1
Study type: Interventional

Open-Label study designed to assess the safety and plasma PK of tretinoin and relevant metabolites after topical dermal application of IDP-121 lotion.

NCT ID: NCT02755545 Completed - Acne Clinical Trials

A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments

Start date: May 1, 2016
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficacy of 2 acne treatments for 24 weeks of use in adult men and women with mild to moderate facial acne, at least 5 inflammatory lesions, and at least 10 - 100 non-inflammatory lesions.

NCT ID: NCT02651220 Completed - Acne Clinical Trials

Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris

Start date: November 2015
Phase: Phase 3
Study type: Interventional

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence and Safety of adapalene and benzoyl peroxide gel, 0.3%/2.5% (Actavis Laboratories UT, Inc.) to Epiduo® Forte (adapalene and benzoyl peroxide) gel 0.3%/2.5% (Galderma) in the treatment of Acne Vulgaris

NCT ID: NCT02593383 Completed - Acne Clinical Trials

Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne

Start date: March 1, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

evaluate the safety and efficacy of Compound Adapalene and Clindamycin Hydrochloride Gel in treatment of chinese patients with acne.

NCT ID: NCT02525549 Completed - Acne Clinical Trials

Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne Vulgaris

Start date: December 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the safety and bioequivalence of Perrigo's product to an FDA approved product for the treatment acne vulgaris.